Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Insulin (resistance).php on line 2
Insulin (resistance)
LE WE PMID CA
Insulin (resistance)1333Insulin (Resistenz)

4 phenylbutyrate

Adipokine

Adiponectin

Adipose tissue (BASKET)

Aldosterone

Autophagy

Burns (Traumatology)

C EBPalpha

CHOP10

D chiro inositol glycans

Diabetes mellitus (Beta cell decay)

Diuretic agents (BASKET)

Donohue s syndrome Leprechaunism

DsbA L

Endothelial dysfunction

eNOS

ERS UFR (Diseases)

ERS UFR (Pharmacology)

Exercise (Physiology)

Ezetimibe

Fatty acids (Free)

Fatty acids (saturated)

FSP27

Hepatitis C

IGF1

Insulin (BASKET)

Insulin (resistance)

JNK1

Lipid rafts and membrane microdomains

Lipocalin

Lipocalin2

Lipotoxicity

Liver (Steatohepatosis)

Macrophages

MAP4k4

Metabolic syndrome

Metformin

Mitochondria (BASKET)

NPC1L1 Niemann Pick C1 Like1

Obesity (BASKET)

PI3K

Polycystic ovary syndrome

Ppargc1alpha

Rabson Mendenhall s syndrome

RBP4

Receptor (Insulin)

Resistin

RIP140

SLC2A4 GLUT4

Tauroursodeoxycholic acid ttchemchaperone

Transporter (Cholesterol)

Tyrosine phosphatase

Uncoupling protein

1999  
1
Insulin resistance syndrome: options for treatment.
[9932820] South Med J 92(1): 2-15 (1999)
1997  
2
The deadly quartet--the insulin resistance syndrome.
[9404899] South Med J 90(12): 1162-8 (1997)
1997  
3
Molecular mechanisms of inherited insulin resistance.
[9349447] QJM 90(9): 557-62 (1997)
2009  
4
Saturated fatty acids and insulin resistance.
[19763019] J Med Invest 56(3-4): 88-92 (2009)
1989  
5
Molecular genetics of severe insulin resistance.
[2697987] Yale J Biol Med 62(5): 533-47 (1989)
2008  
6
Insulin resistance: a potential new target for therapy in patients with heart failure.
[18786090] Cardiovasc Ther 26(3): 203-13 (2008)
2006  
7
Insulin resistance as a membrane microdomain disorder.
[16880599] Biol Pharm Bull 29(8): 1532-7 (2006)
2001  
8
An overview of pathophysiology and treatment of insulin resistance.
[11211569] Indian J Physiol Pharmacol 45(1): 22-36 (2001)
2008  
9
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability.
[18604303] Mediators Inflamm 2008(-): 767623 (2008)
1995  
10
Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms.
[7900697] Am J Clin Nutr 61(4 Suppl): 980S-986S (1995)
2001  
11
Insulin resistance in polycystic ovary syndrome: progress and paradoxes.
[11237218] Recent Prog Horm Res 56(-): 295-308 (2001)
2001  
12
Insulin resistance and its treatment by thiazolidinediones.
[11237217] Recent Prog Horm Res 56(-): 265-94 (2001)
2007  
13
Molecular mechanism of insulin resistance.
[17435330] J Biosci 32(2): 405-13 (2007)
2006  
14
Spectrum of renal diseases associated with extreme forms of insulin resistance.
[17699267] Clin J Am Soc Nephrol 1(4): 616-22 (2006)
2008  
15
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
[18445751] Am J Physiol Endocrinol Metab 295(1): E17-28 (2008)
2008  
16
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.
[17957034] Am J Physiol Endocrinol Metab 294(1): E15-26 (2008)
2007  
17
Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism.
[17077342] Am J Physiol Endocrinol Metab 292(3): E654-67 (2007)
2002  
18
2008  
19
Role of mitochondrial dysfunction in insulin resistance.
[18309108] Circ Res 102(4): 401-14 (2008)
2002  
20
Why test the children?: Understanding insulin resistance, its complications, and its progression.
[12453984] Diabetes Care 25(12): 2350-1 (2002)
2008  
21
How to measure hepatic insulin resistance?
[19195628] Diabetes Metab 34(6 Pt 2): 664-73 (2008)
2008  
22
Mitochondrial energetics and insulin resistance.
[18202132] Endocrinology 149(3): 950-4 (2008)
2005  
23
Insulin resistance and steatosis in hepatitis C virus infection.
[15951532] Gut 54(7): 903-6 (2005)
2000  
24
Insulin sensitivity and its measurement: structural commonalities among the methods.
[11134088] J Clin Endocrinol Metab 85(12): 4426-33 (2000)
1998  
25
Clinical review 97: Syndromes of severe insulin resistance.
[9745395] J Clin Endocrinol Metab 83(9): 3025-30 (1998)
2008  
26
Insulin sensitivity: modulation by nutrients and inflammation.
[18769626] J Clin Invest 118(9): 2992-3002 (2008)
2009  
27
Molecular mechanisms of insulin resistance in chronic hepatitis C.
[19764085] World J Gastroenterol 15(35): 4356-64 (2009)
2005  
28
Insulin resistance: a metabolic pathway to chronic liver disease.
[16250043] Hepatology 42(5): 987-1000 (2005)
2008  
29
RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27.
[18171433] Acta Physiol (Oxf) 192(1): 103-15 (2008)
2006  
30
2010  
31
Adiponectin in insulin resistance: lessons from translational research.
[19906806] Am J Clin Nutr 91(1): 258S-261S (2010)
2008  
32
Postburn trauma insulin resistance and fat metabolism.
[17957035] Am J Physiol Endocrinol Metab 294(1): E1-9 (2008)
2007  
33
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
[17586614] Am J Physiol Heart Circ Physiol 293(4): H2009-23 (2007)
2010  
34
Acyl-CoA synthesis, lipid metabolism and lipotoxicity.
[19818872] Biochim Biophys Acta 1801(3): 246-51 (2010)
2010  
35
Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms.
[19796706] Biochim Biophys Acta 1801(3): 252-65 (2010)
2007  
36
Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance.
[17438370] Cell Cycle 6(8): 888-94 (2007)
2011  
37
Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.
[22039318] World J Gastroenterol 17(36): 4055-62 (2011)
2010  
38
Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization.
[20419831] World J Gastroenterol 16(16): 1943-52 (2010)
2004  
39
Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy.
[15304632] Physiology (Bethesda) 19(-): 183-90 (2004)
2007  
40
Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
[17699878] Physiology (Bethesda) 22(-): 252-60 (2007)
2008  
41
Mechanistic insights into diuretic-induced insulin resistance.
[18981323] Hypertension 52(6): 1009-11 (2008)
2010  
42
Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity.
[19917873] Hypertension 55(1): 15-7 (2010)
2005  
43
Mechanisms of insulin resistance in humans and possible links with inflammation.
[15824195] Hypertension 45(5): 828-33 (2005)
2010  
44
The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.
[20056946] Circ Res 106(1): 58-67 (2010)
2007  
45
Innate immune pathway links obesity to insulin resistance.
[17556663] Circ Res 100(11): 1531-3 (2007)
2007  
46
The macrophage at the crossroads of insulin resistance and atherosclerosis.
[17556668] Circ Res 100(11): 1546-55 (2007)
2010  
47
Pathogenesis of insulin resistance in skeletal muscle.
[20445742] J Biomed Biotechnol 2010(-): 476279 (2010)
2010  
48
Skeletal muscle insulin resistance in endocrine disease.
[20300436] J Biomed Biotechnol 2010(-): 527850 (2010)
2009  
49
Hepatic triacylglycerol accumulation and insulin resistance.
[18997164] J Lipid Res 50 Suppl(-): S74-9 (2009)
2002  
50
Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance.
[12050202] J Clin Endocrinol Metab 87(6): 2474-80 (2002)
2010  
51
Limitations in surrogate measures of insulin resistance.
[21051585] J Clin Endocrinol Metab 95(11): 4874-6 (2010)
2004  
52
Insulin resistance syndrome in children.
[15181020] J Clin Endocrinol Metab 89(6): 2526-39 (2004)
2010  
53
Hypoadiponectinemia--cause or consequence of human "insulin resistance"?
[20164291] J Clin Endocrinol Metab 95(4): 1544-54 (2010)
2007  
54
Does insulin resistance need resistin?
[17554055] J Clin Endocrinol Metab 92(6): 2036-7 (2007)
2008  
55
An integrated view of insulin resistance and endothelial dysfunction.
[18775359] Endocrinol Metab Clin North Am 37(3): 685-711, ix-x (2008)
2008  
56
2007  
57
IGF-I treatment of insulin resistance.
[17785698] Eur J Endocrinol 157 Suppl 1(-): S51-6 (2007)
2010  
58
The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.
[19861693] Endocr Rev 31(1): 25-51 (2010)
2007  
59
Cardiovascular actions of insulin.
[17525361] Endocr Rev 28(5): 463-91 (2007)
2009  
60
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
[19056992] Endocr Rev 30(1): 1-50 (2009)
2004  
61
Mouse models of insulin resistance.
[15044684] Physiol Rev 84(2): 623-47 (2004)
2007  
62
Disordered lipid metabolism and the pathogenesis of insulin resistance.
[17429039] Physiol Rev 87(2): 507-20 (2007)
2008  
63
Inflammation and insulin resistance.
[18053812] FEBS Lett 582(1): 97-105 (2008)
2007  
64
Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2?
[17202496] Clin Chem 53(1): 5-7 (2007)
2004  
65
Tissue-specific insulin resistance.
[15299149] Postgrad Med J 80(946): 435 (2004)
2009  
66
Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance.
[20047129] Swiss Med Wkly 139(47-48): 678-84 (2009)
2007  
67
Antioxidants: do they have a role in the treatment of insulin resistance?
[17496361] Indian J Med Res 125(3): 355-72 (2007)
2010  
68
Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes.
[19799964] Mol Cell Endocrinol 318(1-2): 44-53 (2010)
2008  
69
Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms.
[18580184] Anesthesiology 109(1): 137-48 (2008)
2010  
70
Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.
[20508742] Mediators Inflamm 2010(-): 219583 (2010)
2007  
71
Mechanisms of obesity-associated insulin resistance: many choices on the menu.
[17575046] Genes Dev 21(12): 1443-55 (2007)
2008  
72
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
[18401346] Nat Rev Mol Cell Biol 9(5): 367-77 (2008)
2010  
73
D-chiro-inositol glycans in insulin signaling and insulin resistance.
[20811656] Mol Med 16(11-12): 543-52 (2010)
2008  
74
Inflammatory mechanisms in the regulation of insulin resistance.
[18235842] Mol Med 14(3-4): 222-31 (2008)
2004  
75
Adiponectin and its role in the obesity-induced insulin resistance and related complications.
[15046547] Physiol Res 53(2): 123-9 (2004)
2007  
76
2009  
77
Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin.
[19875582] Diabetes Care 32 Suppl 2(-): S362-7 (2009)
2009  
78
Where does insulin resistance start? The brain.
[19875547] Diabetes Care 32 Suppl 2(-): S174-7 (2009)
2009  
79
Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.
[19875546] Diabetes Care 32 Suppl 2(-): S168-73 (2009)
2009  
80
Viewpoints on the way to a consensus session: where does insulin resistance start? The liver.
[19875545] Diabetes Care 32 Suppl 2(-): S164-7 (2009)
2009  
81
Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.
[19875544] Diabetes Care 32 Suppl 2(-): S157-63 (2009)
2006  
82
Third Annual World Congress on the Insulin Resistance Syndrome: mediators, antecedents, and measurement.
[16801606] Diabetes Care 29(7): 1700-6 (2006)
2010  
83
cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.
[20452774] Trends Biochem Sci 35(9): 490-6 (2010)
2003  
84
Molecular mechanism of insulin resistance and obesity.
[14610248] Exp Biol Med (Maywood) 228(10): 1111-7 (2003)
2010  
85
Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men.
[20739510] Am J Physiol Endocrinol Metab 299(5): E752-63 (2010)
2009  
86
Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance.
[19654286] Am J Physiol Endocrinol Metab 297(5): E1030-8 (2009)
2010  
87
Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes.
[20864818] Autophagy 6(8): 1196-7 (2010)
2007  
88
Repression of GLUT4 expression by the endoplasmic reticulum stress response in 3T3-L1 adipocytes.
[17698029] Biochem Biophys Res Commun 362(1): 188-92 (2007)
2010  
89
Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.
[20519119] Cell Metab 11(6): 467-78 (2010)
2007  
90
Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus.
[17311546] Curr Neurovasc Res 4(1): 63-71 (2007)
2011  
91
Obesity, insulin resistance and free fatty acids.
[21297467] Curr Opin Endocrinol Diabetes Obes 18(2): 139-43 (2011)
2011  
92
Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans.
[21270237] Diabetes 60(3): 918-24 (2011)
2010  
93
Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.
[20522594] Diabetes 59(8): 1899-905 (2010)
2004  
94
An inflammatory cascade leading to hyperresistinemia in humans.
[15578112] PLoS Med 1(2): e45 (2004)
2011  
95
Hepatitis C virus infection: molecular pathways to insulin resistance.
[22008087] Virol J 8(-): 474 (2011)
2009  
96
Acute insulin resistance following injury.
[19800814] Trends Endocrinol Metab 20(9): 429-35 (2009)
2010  
97
Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue?
[19815442] Diabetes Metab 36(1): 11-20 (2010)
2008  
98
Insulin resistance and steatosis in humans.
[19195626] Diabetes Metab 34(6 Pt 2): 649-57 (2008)
2009  
99
Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
[19349201] Diabetes Metab 35(3): 159-67 (2009)
2009  
100
Role of macrophage tissue infiltration in obesity and insulin resistance.
[19539513] Diabetes Metab 35(4): 251-60 (2009)
2008  
101
Adipokines: the missing link between insulin resistance and obesity.
[18093861] Diabetes Metab 34(1): 2-11 (2008)
2006  
102
New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy.
[16642961] Obesity (Silver Spring) 14 Suppl 1(-): 34S-40S (2006)
2009  
103
Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
[19487712] Ann Intern Med 150(11): 776-83 (2009)
2004  
104
Molecular mechanisms of insulin resistance that impact cardiovascular biology.
[15504952] Diabetes 53(11): 2735-40 (2004)
2003  
105
Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?
[12502486] Diabetes 52(1): 1-8 (2003)
2007  
106
Diabetes and suppressors of cytokine signaling proteins.
[17259405] Diabetes 56(2): 541-8 (2007)
2006  
107
Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin.
[16873706] Diabetes 55(8): 2392-7 (2006)
2007  
108
Insulin resistance as a membrane microdomain disorder.
[17409686] Yakugaku Zasshi 127(4): 579-86 (2007)
2010  
109
Lipid-induced insulin resistance: unravelling the mechanism.
[20609972] Lancet 375(9733): 2267-77 (2010)
2008  
110
Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise.
[18801860] Phys Ther 88(11): 1279-96 (2008)
2011  
111
Insulin resistance and chronic liver disease.
[21731901] World J Hepatol 3(5): 99-107 (2011)
2010  
112
Molecular mechanisms of insulin resistance in type 2 diabetes mellitus.
[21537430] World J Diabetes 1(3): 68-75 (2010)
2010  
113
Surrogate markers of insulin resistance: A review.
[21537426] World J Diabetes 1(2): 36-47 (2010)
2010  
114
Molecular mechanism of insulin resistance in obesity and type 2 diabetes.
[20526383] Korean J Intern Med 25(2): 119-29 (2010)
2009  
115
The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action.
[19283361] Diabetologia 52(5): 752-64 (2009)
2002  
116
D-chiro-inositol--its functional role in insulin action and its deficit in insulin resistance.
[11900279] Int J Exp Diabetes Res 3(1): 47-60 (2002)
2010  
117
Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction.
[19766267] Metabolism 59(1): 70-85 (2010)
2006  
118
Uncoupling proteins: role in insulin resistance and insulin insufficiency.
[18220632] Curr Diabetes Rev 2(3): 271-83 (2006)
2011  
119
Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance.
[21176778] FEBS Lett 585(2): 269-74 (2011)
PMC   
120
Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people.
[24651439] Cell Death Dis 5():e1136 (2014)
PMC   
121
Hypoadiponectinemia in obesity: association with insulin resistance.
[24426202] Indian J Clin Biochem 28(2):158-63 (2013)
PMC   
122
Serum adipocyte fatty acid-binding protein in the critically ill.
[23463959] Crit Care 17(2):121 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Insulin (resistance).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Insulin (resistance).php on line 92